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Down syndrome, or trisomy 21, is by far the most
common and best known chromosome disorder and is the
single most common genetic cause of moderate mental
retardation. About one child in 800 is born with Down
syndrome, and the incidence is much higher among the
live births or fetuses of mothers 35 years of age or older
(1).
About three quarters of all Down syndrome
conceptuses are lost through spontaneous abortion either
in the first trimester or, less frequently, later in
pregnancy, and many live-born children with the
syndrome die in early postnatal life (1).
The clinical diagnosis of Down syndrome usually
presents no particular difficulty. Nevertheless, karyotping
is indicated for confirmation and to provide a basis for
genetic counseling. Although the particular karyotpe
responsible for Down syndrome has little if any effect on
the phenotype of the patient, it is essential for
determining the risk of recurrence (1).
We here present a family with a boy with 21q;21qtype translocation of Down syndrome. He was six years
old. His clinical presentation included the classical findings
of Down syndrome. We found 46,XY, -21, + t(21q;21q)
chromosomal consitution in all metaphases obtained from
peripheral blood cells of the child (Figure 1). Then we
examined his parents. Both spouses were 32 years old.
They were healthy people with no consanguinity between
them. Following cytogenetic studies, it was determined
that they were not carriers for 21q;21q translocation.
Their chromosomal structures were normal. The boy’s
mother was admitted counseling for her most recent
pregnancy; from her history we learned that the had
gravidity 3, parity 1, and D&C 1. The second pregnancy
was terminated by D&C at the 7th week of gestational age
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at the parents’ wishes two years ago. This pregnancy was
at the 15th week of gestational age. We performed
amniocentesis during the 16th week of gestational age;
fetal karyotype revealed 46,XX. This pregnancy resulted
in the birth of a healthy female child. After delivery,
cytogenetic tests were conducted on chord blood to
confirm the amniotic results. The results of the tests were
identical.
In about 95% of all patients, Down syndrome involves
trisomy for chromosome 21, resulting from meiotic
nondisjunction of the 21st chromosome pair (1). A
21q:21q translocation chromosome is a chromosme
made up of two long arms of chromosome 21, seen
occasionally in Down syndrome carriers or patients (1). It
is thought to originate as an isochromosome rather than
by Robertsonian translocation (an attachment of two
different chromosome 21 homologues). Although this is
a rare abnormality, it is particularly important because all
gametes of a carrier of such a chromosome must
eitherontain the 21q:21q chromosome with its double
amount of chromosome 21 genetic material, or lack it
and have no chromosome 21 representative at all. The
potential progeny inevitably have either Down syndrome
or monosomy 21, which is rarely viable (2, 3). An
individual unfortunate enough to have this defect is
unable to have normal children and will probably have
only children with Down syndrome (1).
The recurrence risk for Down syndrome is about 1%
in the case of a previous offspring with trisomy 21 and
minimal in case of de novo 21q:21q translocation (4). For
this reason we performed amniocentesis during the 16th
week of gestational age; thus we also eliminated the
chance of Down syndrome which might have originated
from paternal or maternal gonadal mosacism. Although
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Figure 1.

Metaphase plaque (GT-banding). The 21q;21q translocation is shown with an arrow.

the mother’s and the father’s chromosomal structures
obtained from peripheral blood lymphocytes were found
to be normal, we performed amiocentesis to eliminate
gonadal mosaicism. In genetic counseling, the posibility of

an elevated recurrence risk due to gonadal mosaicism in
one of the parents should be considered (4). If one spouse
was a carrier of 21q:21q translocation, this family would
certainly have a baby with Down syndrome. On the other
hand, nearly all 21q:21q translocations and
isochromosomes (more than 95%) occur de novo and the
larges class of de novo chromosomal rearrangements in
Down syndrome is 21q;21q translocation (5).
Furthermore, a Robertsonian translocation between two
21st chromosomes can not be distinguished from an
isochromosome composed of genetically identical arms by
cytogenetic analyses (6). Molecular techniques are
necessary for differentiation between Robertsonian
translocations and isochromosomes. To distinguish
between Robertsonian 21q;21q translocation and
isochromsome 21q, Restriction fragment length
polymorphisms (RELPs) spanning the length of
chromosome 21 are lost frequently used for
distinguishing between Robertsonian translocations and
isochrome 21q.
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